Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Testi

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Blood Cancer Journal|November 5, 2016
High-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large B-cell lymphoma patients with MYC/BCL2 co-expressionF Maura, A Guidetti, A Pellegrinelli, et al.
Blood Cancer Journal|March 18, 2017
High-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large B-cell lymphoma patients with MYC/BCL2 co-expressionF Maura, A Guidetti, A Pellegrinelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Effect of protracted high-dose L-asparaginase given as a second exposure in a Berlin-Frankfurt-Münster-based treatment: results of the randomized 9102 intermediate-risk childhood acute lymphoblastic leukemia study--a report from the Associazione Italiana Ematologia Oncologia PediatricaC Rizzari, M G Valsecchi, M Aricò, et al.
Oncogene|August 19, 2000
A novel zinc finger gene is fused to EWS in small round cell tumorT Mastrangelo, P Modena, S Tornielli, et al.
Human Mutation|October 2, 2004
Germline mutations of the POU6F2 gene in Wilms tumors with loss of heterozygosity on chromosome 7p14Daniela Perotti, Giovanna De Vecchi, Maria A Testi, et al.
Leukemia|January 12, 2019
Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphomaA Dodero, A Guidetti, A Tucci, et al.
Haematologica|November 24, 1998
Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia PediatricaV Conter, M Aricò, M G Valsecchi, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Blood Cancer Journal|November 5, 2016
High-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large B-cell lymphoma patients with MYC/BCL2 co-expressionF Maura, A Guidetti, A Pellegrinelli, et al.
Blood Cancer Journal|March 18, 2017
High-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large B-cell lymphoma patients with MYC/BCL2 co-expressionF Maura, A Guidetti, A Pellegrinelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Effect of protracted high-dose L-asparaginase given as a second exposure in a Berlin-Frankfurt-Münster-based treatment: results of the randomized 9102 intermediate-risk childhood acute lymphoblastic leukemia study--a report from the Associazione Italiana Ematologia Oncologia PediatricaC Rizzari, M G Valsecchi, M Aricò, et al.
Oncogene|August 19, 2000
A novel zinc finger gene is fused to EWS in small round cell tumorT Mastrangelo, P Modena, S Tornielli, et al.
Human Mutation|October 2, 2004
Germline mutations of the POU6F2 gene in Wilms tumors with loss of heterozygosity on chromosome 7p14Daniela Perotti, Giovanna De Vecchi, Maria A Testi, et al.
Leukemia|January 12, 2019
Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphomaA Dodero, A Guidetti, A Tucci, et al.
Haematologica|November 24, 1998
Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia PediatricaV Conter, M Aricò, M G Valsecchi, et al.
Pageof 2